Koncentrationen af adalimumab i synovialvæsken fra adskillige reumatoid artrit - patienter målt i serum var 31– 96%.
Adalimumab concentrations in the synovial fluid from several rheumatoid arthritis patients ranged from 31-96% of those in serum.